0.919
price up icon8.50%   0.072
pre-market  Pre-mercato:  .95   0.031   +3.37%
loading
Precedente Chiudi:
$0.847
Aprire:
$0.86
Volume 24 ore:
519.41K
Relative Volume:
0.68
Capitalizzazione di mercato:
$8.54M
Reddito:
$2.05M
Utile/perdita netta:
$-23.15M
Rapporto P/E:
-0.1386
EPS:
-6.6319
Flusso di cassa netto:
$-16.93M
1 W Prestazione:
+3.27%
1M Prestazione:
-79.16%
6M Prestazione:
-67.75%
1 anno Prestazione:
-46.57%
Intervallo 1D:
Value
$0.81
$0.9307
Intervallo di 1 settimana:
Value
$0.6358
$1.00
Portata 52W:
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Nome
iBio Inc
Name
Telefono
302-355-0650
Name
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
IBIO's Discussions on Twitter

Confronta IBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IBIO
iBio Inc
0.919 8.54M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-28 Iniziato Chardan Capital Markets Buy
2021-11-29 Iniziato JMP Securities Mkt Outperform
2021-01-22 Iniziato Cantor Fitzgerald Overweight
2020-06-26 Iniziato Alliance Global Partners Buy

iBio Inc Borsa (IBIO) Ultime notizie

pulisher
07:24 AM

Analytical Overview: TMC the metals company Inc (TMC)’s Ratios Tell a Financial Story - DWinneX

07:24 AM
pulisher
07:24 AM

Financial Metrics Unveiled: CISO Global Inc (CISO)’s Key Ratios in the Spotlight - DWinneX

07:24 AM
pulisher
Apr 25, 2025

iBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 25, 2025

AstralBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 24, 2025

iBio Inc (IBIO) expanding its growth trajectory ahead - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Monitoring iBio Inc (IBIO) after recent insider movements - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

In the Green: iBio Inc (IBIO) Closes at 0.70, Up/Down -17.43 from Previous Day - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Ibio Inc Enters Exclusive License Agreement With AstralBio - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Enters Licensing Agreement for Obesity Treatment - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Inc (IBIO) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Breaking down IBIO’s current quarter earnings estimates - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Revolutionary AI-Discovered Obesity Drug: iBio Licenses First-Ever Activin E Antibody in $28M Deal - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Porch Group Inc (PRCH) Stock: A Year of Stock Market Dynamics - investchronicle.com

Apr 22, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia

Apr 16, 2025
pulisher
Apr 08, 2025

iBio Highlights Advancements in Obesity Antibody Programs - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

iBio Inc (NASDAQ: IBIO): Time To Buy Over The Next Few Months - Marketing Sentinel

Apr 08, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Where Do Analysts Think The iBio Inc (NASDAQ: IBIO) Is Going - stocksregister.com

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish - MSN

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio reports preclinical results for antibodies in cardiometabolic and obesity pipeline - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio IncOn Track For Regulatory Submission For Ibio-600 In Q1 2026 - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Reveals Promising Study Results for IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

iBio announces data from non-human primate PK study of IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Game-Changing Clinical Data: iBio's New Drug Combines Muscle Growth with Massive Weight Loss - Stock Titan

Apr 07, 2025
pulisher
Apr 06, 2025

Senior Mining ExecutiveFrederic Mercier-Langevin to Join Patriot Battery Metals - The Globe and Mail

Apr 06, 2025
pulisher
Apr 03, 2025

Hartford Insurance Group Inc.(The) [HIG] Officer makes an insider purchase of 1,144 shares worth 0.14 million. - knoxdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Galaxy Digital UK Secures FCA License, Expanding Derivatives Trading Capabilities in London - The Globe and Mail

Apr 02, 2025
pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 04, 2025

IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView

Mar 04, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

iBio Inc [IBIO] gain 106.12% so far this year. What now? - dbtnews.com

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025

iBio Inc Azioni (IBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):